Unique ID issued by UMIN | UMIN000037845 |
---|---|
Receipt number | R000043147 |
Scientific Title | Exploratory evaluation of glycemic control improvement of patients with diabetes by appropriate insulin injection technique |
Date of disclosure of the study information | 2019/10/15 |
Last modified on | 2022/10/13 09:38:53 |
Exploratory evaluation of glycemic control improvement of patients with diabetes by appropriate insulin injection technique
Exploratory evaluation of glycemic control improvement
Exploratory evaluation of glycemic control improvement of patients with diabetes by appropriate insulin injection technique
Exploratory evaluation of glycemic control improvement
Japan |
Diabetes mellitus
Endocrinology and Metabolism |
Others
NO
To evaluate improvement of glycemic control by implementing appropriate education on insulin injection techniques and the new pen needle for insulin injection to those patients with diabetes who undergo insulin therapy
Efficacy
Exploratory
Pragmatic
Not applicable
Absolute mean reduction in HbA1c between the baseline and the end of the observation period
1)Number and percentage of patients with reduced HbA1c at the end of the observation period
2)Reduction rate in HbA1c between the baseline and the end of the observation period
3)Absolute mean reduction in total daily insulin dose between the baseline and the end of the observation period
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1)Female and male outpatients with diabetes aged at 20 or over
2)Patients with insulin injection history of 1 years or more
3)Patients with no history of hospitalization within six months prior to the enrollment
4)Patients with insulin injection 3+ times a day
5)Patients on the new pen needle for insulin injection or will be prescribed with it
6)Patients with ability to understand and execute instructed insulin injection technique
7)Patients with ability to provide written informed consent
1)Pregnant patients or patients with suspected pregnancy
2)Patients who take steroid treatment with dose changing in follow-up period
3)Patients with malignant disease undergoing treatment.
4)Patients whom a principal investigator determines as inappropriate
5)Patients who refuse to provide an informed consent or to participate in this study
120
1st name | Akihiro |
Middle name | |
Last name | Hamasaki |
Tazuke Kofukai Medical Research Institute Kitano Hospital
Department of Diabetes and Endocrinology
530-8480
2-4-20, Ohgi-machi Kita-ku, Osaka, 530-8480 Japan
06-6312-1221
a-hamasaki@kitano-hp.or.jp
1st name | Shusaku |
Middle name | |
Last name | Tozaka |
Nippon Becton Dickinson Company, Ltd.
Medical Affairs
107-0052
4-15-1, Akasaka, Minato-ku, Tokyo, 107-0052 Japan
03-6234-5628
shusaku_tozaka@bd.com
Tazuke Kofukai Medical Research Institute Kitano Hospital
Nippon Becton Dickinson Company, Ltd.
Profit organization
Tazuke Kofukai Medical Research Institute Kitano Hospital
2-4-20, Ohgi-machi Kita-ku, Osaka, 530-8480 Japan
06-6312-1221
rinshou@kitano-hp.or.jp
NO
公益財団法人田附興風会医学研究所北野病院(大阪府)
2019 | Year | 10 | Month | 15 | Day |
Unpublished
Completed
2019 | Year | 09 | Month | 30 | Day |
2019 | Year | 10 | Month | 09 | Day |
2019 | Year | 11 | Month | 01 | Day |
2020 | Year | 11 | Month | 30 | Day |
2021 | Year | 01 | Month | 31 | Day |
2021 | Year | 02 | Month | 28 | Day |
2021 | Year | 04 | Month | 30 | Day |
-
2019 | Year | 08 | Month | 29 | Day |
2022 | Year | 10 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043147